Joseph Paul Eder, MD

Articles by Joseph Paul Eder, MD

Prospects for Targeting PD-1 and PD-L1 in Various Tumor Types

ByJoseph W. Kim, MD,Joseph Paul Eder, MD

November 11th 2014

In this review, we will discuss the current status of several anti–PD-1 and anti–PD-L1 antibodies in clinical development and their direction for the future.

Latest Updated Articles

Prospects for Targeting PD-1 and PD-L1 in Various Tumor Types
Published: November 11th 2014 | Updated:

Joseph Paul Eder, MD

Articles by Joseph Paul Eder, MD

Prospects for Targeting PD-1 and PD-L1 in Various Tumor Types

Latest Updated Articles

Trending on CancerNetwork

Antiemetic Regimen Limits Chemo-Induced Nausea/Vomiting in Multiple Myeloma

Casdatifan Monotherapy Achieves Clinical Activity in Late-Line Kidney Cancer

Addressing Early Talquetamab Toxicity Concerns

FDA Grants Priority Review to BLA for Orca-T in Hematologic Malignancies

Cryoablation Regimen Receives FDA Marketing Authorization for Breast Cancer